Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2007

Mar 2, 2007

30339_dirs_2007-03-02_e60b584d-1a97-4394-8a88-1f8995933e73.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2007-02-28

Reporting Person: McMillan Donald A (President Pharma Systems NA)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-02-28 Common Stock F 37.3444 $45.3500 Disposed 8001.9595 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6007.8696 Indirect
Common Stock 1047.9100 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.